Welcome to LookChem.com Sign In|Join Free
  • or
1-fluoro-3-nitro-2-thiocyanatobenzene is an organic compound with the molecular formula C7H3FN2O2S2. It is a derivative of benzene, featuring a fluorine atom at the 1-position, a nitro group at the 3-position, and a thiocyanate group at the 2-position. 1-fluoro-3-nitro-2-thiocyanatobenzene is characterized by its yellow crystalline appearance and is known for its potential applications in the synthesis of various chemical compounds and materials. Due to the presence of both electron-withdrawing and electron-donating groups, it exhibits unique chemical properties that can be exploited in various reactions. However, it is important to handle 1-fluoro-3-nitro-2-thiocyanatobenzene with care, as it may have potential health and environmental hazards.

21325-05-3

Post Buying Request

21325-05-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21325-05-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 21325-05-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,2 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 21325-05:
(7*2)+(6*1)+(5*3)+(4*2)+(3*5)+(2*0)+(1*5)=63
63 % 10 = 3
So 21325-05-3 is a valid CAS Registry Number.

21325-05-3Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 183, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Paragraph 0757, (2014/09/30)

Compounds of general formula I: and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 197, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 21325-05-3